News & Events

19 Apr 2023
MENARINI ANNOUNCES AN EXCLUSIVE DISTRIBUTION AGREEMENT FOR BODITECH’S AFIAS-10 SYSTEM
FLORENCE, ITALY, April 19 ᵗʰ  2023 , A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others), building on several years of...
Read More
20 Mar 2023
ECCMID 2023
Copenhagen, 15 - 18 April 2023
Read More
06 Mar 2023
CORA 2023
Turin, Italy, 16-18 March 2023
Read More
02 Mar 2023
XII Portuguese Congress of Clinical Pathology
Figueira da Foz, 2- 4 March 2023
Read More
13 Feb 2023
ATTD 2023
Berlin, 22-25 February 2023
Read More
10 Feb 2023
37th Postgraduate Biopathology Seminar
Thessaloniki, Greece, 10 -12 February 2023
Read More
06 Feb 2023
Medlab Middle East 2023
Dubai, United Arab Emirates, 6 - 9 February 2023
Read More
02 Feb 2023
PORTUGUESE CONGRESS OF ENDOCRINOLOGY
2-5 February 2023, at the Algarve Congress Centre, in Vilamoura, Portugal
Read More
02 Nov 2022
QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform
  NEWCASTLE UPON TYNE, UK and FLORENCE, ITALY, 2nd November 2022 , QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational Point-of-Need molecular diagnostics, and A.Menarini Diagnostics S.r.I. ...
Read More
01 Jul 2022
EASD 2022
Stockholm, 19 - 23 September 2022 
Read More
Page 2 of 5First   Previous   1  [2]  3  4  5  Next   Last   

Our Values

4 values, which have given life to Menarini and shaped its history

READ MORE »